Phase 3Completed

Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis (PNE)

A Double-blind, Placebo-controlled, Phase III Comparative Study With FE992026 in Children and Adolescents With Reduced Night-time Urinary Osmolarity-type Nocturnal Enuresis

Sponsor
Ferring Pharmaceuticals (Industry)
Enrollment
89 enrolled
Conditions
Nocturnal Enuresis
Interventions
Desmopressin; Placebo
Ages
children
Registry
NCT01078753

Full record on ClinicalTrials.gov

From the registry

This is multi-center, randomized, placebo-controlled, parallel-group, double-blind, dose-escalating clinical trial designed to assess the efficacy and safety of desmopressin orally lyophilisate for the treatment of nocturnal enuresis "with decreased nighttime urinary osmolality."

Primary outcomes

  • Change in the Number of Wet Nights Between Baseline and Treatment Period II

History

  1. Results first posted

  2. Last registry update

  3. Primary completion

  4. Registered

  5. Started